Search results
Johnson & Johnson faces new class action lawsuit on behalf of talc users
FOX Business· 4 days agoJohnson & Johnson says its talc is safe, asbestos-free and does not cause cancer, and that...
AstraZeneca drug regimen approved for endometrial cancer
Becker’s Hospital Review· 6 days agoThe study was published in October in the Journal of Clinical Oncology. It found that overall Imfinzi was well tolerated and safety was consistent with previous trials, according to a June 17 ...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoKEYTRUDA plus carboplatin and paclitaxel followed by KEYTRUDA alone reduced the disease progression...
J&J Talc Users Want Cancer Monitoring Even If It Cost Billions
Bloomberg· 6 days agoHave a confidential tip for our reporters? Johnson & Johnson should be on the hook for potentially...
J&J Faces New Class Action Suit Seeking Damages And Medical Monitoring For Cancer
International Business Times· 4 days agoJohnson & Johnson is facing another proposed class action lawsuit seeking damages and medical monitoring for women who allegedly developed cancer due to the company's talc ...
Zentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths
FierceBiotech· 5 days agoThe FDA has placed three trials of Zentalis’ WEE1 candidate on partial hold in the wake of two...
Abbott Laboratories (NYSE:ABT) Shares Bought by Fisher Asset Management LLC
ETF DAILY NEWS· 6 days agoFisher Asset Management LLC lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.4% during the 4th quarter, according to its most recent disclosure with the SEC ...
Willner & Heller LLC Takes Position in Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 6 days agoWillner & Heller LLC purchased a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 6,023 shares of the healthcare ...
